Post-transplant lymphoproliferative disorder

Clinics in Chest Medicine

Volumn 26, Issue 4, 2005, Pages 631-645

  Loren, Alison W ^a,b   Tsai, Donald E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN; GANCICLOVIR; RITUXIMAB; TACROLIMUS;

ARTICLE; CANCER STAGING; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EPSTEIN BARR VIRUS; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LABORATORY TEST; LIVER FUNCTION; LYMPHOPROLIFERATIVE DISEASE; PERIODIC MEDICAL EXAMINATION; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY ANALYSIS;

EID: 27644546314     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.06.014     Document Type: Review

References (105)

1. T.E. Starzl Discussion of: Murray JE, Wilson RE, Tilney NL, et al Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications and the role of lymphocyte depletion by thoracic duct fistula Ann Surg 168 1968 416 435
2. I. Penn, W. Hammond, and L. Brettschneider Malignant lymphomas in transplantation patients Transplant Proc 1 1969 106 112
3. S. Bhatia, N.K. Ramsay, and M. Steinbuch Malignant neoplasms following bone marrow transplantation Blood 87 1996 3633 3639
4. J.M. Armitage, R.L. Kormos, and R.S. Stuart Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression J Heart Lung Transplant 10 1991 877 886 [discussion: 886-7]
5. M.A. Nalesnik Posttransplantation lymphoproliferative disorders (PTLD): current perspectives Semin Thorac Cardiovasc Surg 8 1996 139 148
6. D.E. Tsai, C.L. Hardy, and J.E. Tomaszewski Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long- term follow-up of 42 adult patients Transplantation 71 2001 1076 1088
7. G. Opelz, and B. Dohler Lymphomas after solid organ transplantation: a collaborative transplant study report Am J Transplant 4 2003 222 230
8. R.S. Shapiro, K. McClain, and G. Frizzera Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation Blood 71 1988 1234 1243
9. M.A. Epstein, B.G. Achong, and Y.M. Barr Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet 1 1964 702 703
10. J.I. Cohen Epstein-Barr virus infection N Engl J Med 343 2000 481 492
11. P. Porcu, C.F. Eisenbeis, and R.P. Pelletier Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration Blood 100 2002 2341 2348
12. R. Omiya, C. Buteau, H. Kobayashi, C.V. Paya, and E. Celis Inhibition of EBV-induced lymphoproliferation by CD4(+) T cells specific for an MHC class II promiscuous epitope J Immunol 169 2002 2172 2179
13. V. Leblond, F. Davi, and F. Charlotte Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16 1998 2052 2059
14. B.P. Nelson, M.A. Nalesnik, and D.W. Bahler Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 24 2000 375 385
15. C.V. Paya, J.J. Fung, and M.A. Nalesnik Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting Transplantation 68 1999 1517 1525
16. N.L. Harris, J.A. Ferry, and S.H. Swerdlow Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop Semin Diagn Pathol 14 1997 8 14
17. N.L. Harris, E.S. Jaffe, and J. Diebold World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997 J Clin Oncol 17 1999 3835 3849
18. T.I. George, M. Jeng, and W. Berquist Epstein-Barr virus-associated peripheral T-cell lymphoma and hemophagocytic syndrome arising after liver transplantation: case report and review of the literature Pediatr Blood Cancer 44 2005 270 276
19. H.K. Lee, H.J. Kim, and E.H. Lee Epstein-Barr virus-associated peripheral T-Cell lymphoma involving spleen in a renal transplant patient J Korean Med Sci 18 2003 272 276
20. R. Rajakariar, M. Bhattacharyya, and A. Norton Post transplant T-cell lymphoma: a case series of four patients from a single unit and review of the literature Am J Transplant 4 2004 1534 1538
21. D.E. Tsai, N.A. Aqui, and D.T. Vogl Successful treatment of T-cell posttransplant lymphoproliferative disorder with retinoid analog, bexarotene Am J Transplant 5 2005 2070 2073
22. D.E. Tsai, M. Nearey, and C.L. Hardy Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients Am J Transplant 2 2002 946 954
23. M. Green, and S.A. Webber EBV viral load monitoring: unanswered questions Am J Transplant 2 2002 894 895
24. D.N. Kenagy, Y. Schlesinger, and K. Weck Epstein-Barr virus DNA in peripheral blood leukocytes of patients with posttransplant lymphoproliferative disease Transplantation 60 1995 547 554
25. S.V. McDiarmid, S. Jordan, and G.S. Kim Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients Transplantation 66 1998 1604 1611
26. J. Yang, Q. Tao, and I.W. Flinn Characterization of Epstein-Barr virus-infected B cells in patients with posttransplantation lymphoproliferative disease: disappearance after rituximab therapy does not predict clinical response Blood 96 2000 4055 4063
27. N.A. Aqui, J.E. Tomaszewski, and D. Goodman Use of serum protein electrophoresis to monitor patients with post-transplant lymphoproliferative disorder Am J Transplant 3 2003 1308 1311
28. N. Babel, F. Schwarzmann, and A. Pruss Monoclonal gammopathy of undetermined significance (MGUS) is associated with an increased frequency of Epstein-Barr Virus (EBV) latently infected B lymphocytes in long-term renal transplant patients Transplant Proc 36 2004 2679 2682
29. A. Lemoine, P. Pham, and D. Azoulay Detection of gammopathy by serum protein electrophoresis for predicting and managing therapy of lymphoproliferative disorder in 911 recipients of liver transplants Blood 98 2001 1332 1338
30. S. Feng, J.F. Buell, and R.S. Chari Tumors and transplantation: the 2003 Third Annual ASTS State-of-the-Art Winter Symposium Am J Transplant 3 2003 1481 1487
31. M.A. Nalesnik, L. Makowka, and T.E. Starzl The diagnosis and treatment of posttransplant lymphoproliferative disorders Curr Probl Surg 25 1988 367 472
32. G. Opelz, and R. Henderson Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients Lancet 342 1993 1514 1516
33. P. Ramalingam, L. Rybicki, and M.D. Smith Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience Mod Pathol 15 2002 647 656
34. B.D. Reams, H.P. McAdams, and D.N. Howell Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients Chest 124 2003 1242 1249
35. S.Z. Gao, S.V. Chaparro, and M. Perlroth Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University J Heart Lung Transplant 22 2003 505 514
36. S. Paranjothi, R.D. Yusen, and M.D. Kraus Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases J Heart Lung Transplant 20 2001 1054 1063
37. A.A. Castellano-Sanchez, S. Li, and J. Qian Primary central nervous system posttransplant lymphoproliferative disorders Am J Clin Pathol 121 2004 246 253
38. M. Benkerrou, A. Durandy, and A. Fischer Therapy for transplant-related lymphoproliferative diseases Hematol Oncol Clin North Am 7 1993 467 475
39. D.W. Hanto Retransplantation after post-transplant lymphoproliferative diseases (PTLD): when is it safe? Am J Transplant 4 2004 1733 1734
40. A. Karras, E. Thervet, and Y.L. Meur Successful renal retransplantation after post-transplant lymphoproliferative disease Am J Transplant 4 2004 1904 1909
41. E. Juvonen, S.M. Aalto, and J. Tarkkanen High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment Bone Marrow Transplant 32 2003 97 102
42. M.M. Zutter, P.J. Martin, and G.E. Sale Epstein-Barr virus lymphoproliferation after bone marrow transplantation Blood 72 1988 520 529
43. M.A. Lones, D. Lopez-Terrada, and I.P. Shintaku Posttransplant lymphoproliferative disorder in pediatric bone marrow transplant recipients: disseminated disease of donor origin demonstrated by fluorescence in situ hybridization Arch Pathol Lab Med 122 1998 708 714
44. J.D. Shepherd, R.D. Gascoyne, and M.J. Barnett Polyclonal Epstein-Barr virus-associated lymphoproliferative disorder following autografting for chronic myeloid leukemia Bone Marrow Transplant 15 1995 639 641
45. R.J. Hauke, T.C. Greiner, and B.N. Smir Epstein-Barr virus-associated lymphoproliferative disorder after autologous bone marrow transplantation: report of two cases Bone Marrow Transplant 21 1998 1271 1274
46. M.A. Lones, I. Kirov, and J.W. Said Post-transplant lymphoproliferative disorder after autologous peripheral stem cell transplantation in a pediatric patient Bone Marrow Transplant 26 2000 1021 1024
47. R.A. Nash, R. Dansey, and J. Storek Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases Biol Blood Marrow Transplant 9 2003 583 591
48. A.Y. Ho, S. Adams, and H. Shaikh Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome Bone Marrow Transplant 29 2002 867 869
49. A. Lange, A. Klimczak, and D. Dlubek B-cell lymphoproliferative syndrome and peripheral blood CD20 + cells expansion after hematopoietic stem cell transplantation: association with fludarabine and anti-thymocyte globulin containing conditioning regimen Transplant Proc 35 2003 3093 3095
50. M.J. Snyder, T.T. Stenzel, and P.J. Buckley Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation Am J Surg Pathol 28 2004 794 800
51. G. Hale, and H. Waldmann Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users Blood 91 1998 3079 3083
52. H.E. Heslop Preventing Epstein-Barr virus lymphoproliferative disease after bone marrow transplantation J Immunother 24 2001 283 284
53. M. Benkerrou, J.P. Jais, and V. Leblond Anti-B-cell monoclonal antibody treatment of severe posttransplant B- lymphoproliferative disorder: prognostic factors and long-term outcome Blood 92 1998 3137 3147
54. T.G. Gross, M. Steinbuch, and T. DeFor B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome Bone Marrow Transplant 23 1999 251 258
55. I.N. Micallef, M. Chhanabhai, and R.D. Gascoyne Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience Bone Marrow Transplant 22 1998 981 987
56. R.E. Curtis, L.B. Travis, and P.A. Rowlings Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study Blood 94 1999 2208 2216
57. N. Parry-Jones, T. Haque, and M. Ismail Epstein-Barr virus (EBV) associated B-cell lymphoproliferative disease following HLA identical sibling marrow transplantation for aplastic anaemia in a patient with an EBV seronegative donor Transplantation 67 1999 1373 1375
58. S.A. Riddler, M.C. Breinig, and J.L. McKnight Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients Blood 84 1994 972 984
59. A. Savoie, C. Perpete, and L. Carpentier Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease Blood 83 1994 2715 2722
60. C.M. Rooney, C.A. Smith, and C.Y. Ng Use of gene-modified virus-specific T lymphocytes to control Epstein- Barr-virus-related lymphoproliferation Lancet 345 1995 9 13
61. K.G. Lucas, R.L. Burton, and S.E. Zimmerman Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation Blood 91 1998 3654 3661
62. F. Baldanti, P. Grossi, and M. Furione High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders J Clin Microbiol 38 2000 613 619
63. C.M. Rooney, S.K. Loftin, and M.S. Holladay Early identification of Epstein-Barr virus-associated post- transplantation lymphoproliferative disease Br J Haematol 89 1995 98 103
64. M. Green, J. Bueno, and D. Rowe Predictive negative value of persistent low Epstein-Barr virus viral load after intestinal transplantation in children Transplantation 70 2000 593 596
65. S.A. Birkeland, H.K. Andersen, and S.J. Hamilton-Dutoit Preventing acute rejection, Epstein-Barr virus infection, and posttransplant lymphoproliferative disorders after kidney transplantation: use of aciclovir and mycophenolate mofetil in a steroid-free immunosuppressive protocol Transplantation 67 1999 1209 1214
66. I.A. Darenkov, M.A. Marcarelli, and G.P. Basadonna Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy Transplantation 64 1997 848 852
67. C.L. Davis, K.L. Harrison, and J.P. McVicar Antiviral prophylaxis and the Epstein Barr virus-related post- transplant lymphoproliferative disorder Clin Transplant 9 1995 53 59
68. B.M. Colby, J.E. Shaw, and G.B. Elion Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication J Virol 34 1980 560 568
69. C.S. Crumpacker Ganciclovir N Engl J Med 335 1996 721 729
70. D.V. Faller, S.J. Mentzer, and S.P. Perrine Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein- Barr virus-associated malignancies Curr Opin Oncol 13 2001 360 367
71. S.P. Perrine, O. Hermine, and S.J. Mentzer A phase I/II study of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies Blood 104 2004 176a
72. T.E. Starzl, M.A. Nalesnik, and K.A. Porter Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy Lancet 1 1984 583 587
73. C.L. Davis, B.L. Wood, and D.E. Sabath Interferon-alpha treatment of posttransplant lymphoproliferative disorder in recipients of solid organ transplants Transplantation 66 1998 1770 1779
74. G. Dotti, R. Fiocchi, and T. Motta Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome Transplantation 74 2002 1095 1102
75. A. Faro, G. Kurland, and M.G. Michaels Interferon-alpha affects the immune response in post-transplant lymphoproliferative disorder Am J Respir Crit Care Med 153 4 Pt 1 1996 1442 1447
76. E. Haddad, S. Paczesny, and V. Leblond Treatment of B-lymphoproliferative disorder with a monoclonal anti- interleukin-6 antibody in 12 patients: a multicenter phase 1-2 clinical trial Blood 97 2001 1590 1597
77. L.J. Swinnen, G.M. Mullen, and T.J. Carr Aggressive treatment for postcardiac transplant lymphoproliferation Blood 86 1995 3333 3340
78. M.F. Mamzer-Bruneel, C. Lome, and E. Morelon Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: a report of 16 cases observed in a single center J Clin Oncol 18 2000 3622 3632
79. D. Gill, H.G. Juffs, and K.A. Herzig Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation Transplant Proc 35 2003 256 257
80. A. Faye, T. Van Den Abeele, and M. Peuchmaur Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders Lancet 352 1998 1285
81. A. Fischer, S. Blanche, and J. Le Bidois Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation N Engl J Med 324 1991 1451 1456
82. I. Kuehnle, M.H. Huls, and Z. Liu CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation Blood 95 2000 1502 1505
83. N. Milpied, B. Vasseur, and N. Parquet Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients Ann Oncol 11 Suppl 1 2000 113 116
84. D.H. Crawford, N. Mulholland, and V. Iliescu Epstein-Barr virus infection and immunity in bone marrow transplant recipients Transplantation 42 1986 50 54
85. H. Kook, F. Goldman, and D. Padley Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery Blood 88 1996 1089 1097
86. T.N. Small, E.B. Papadopoulos, and F. Boulad Comparison of immune reconstitution after unrelated and related T-cell- depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions Blood 93 1999 467 480
87. N.A. Marshall, J.G. Howe, and R. Formica Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation Blood 96 2000 2814 2821
88. K. Kuzushima, H. Kimura, and Y. Hoshino Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder J Infect Dis 182 2000 937 940
89. K.G. Lucas, T.N. Small, G. Heller, B. Dupont, and R.J. O'Reilly The development of cellular immunity to Epstein-Barr virus after allogeneic bone marrow transplantation Blood 87 1996 2594 2603
90. V.P. Khatri, R.A. Baiocchi, and R. Peng Endogenous CD8 + T cell expansion during regression of monoclonal EBV- associated posttransplant lymphoproliferative disorder J Immunol 163 1999 500 506
91. D.L. Porter, G.J. Orloff, and J.H. Antin Donor mononuclear cell infusions as therapy for B-cell lymphoproliferative disorder following allogeneic bone marrow transplant Transplant Sci 4 1994 12 14 [discussion 14-6]
92. E.B. Papadopoulos, M. Ladanyi, and D. Emanuel Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation N Engl J Med 330 1994 1185 1191
93. C.M. Rooney, C.A. Smith, and C.Y. Ng Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients Blood 92 1998 1549 1555
94. A. Gustafsson, V. Levitsky, and J.Z. Zou Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells Blood 95 2000 807 814
95. M.L. Gulley, L.J. Swinnen, and K.T. Plaisance Jr Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy Transplantation 76 2003 959 964
96. C.M. Bollard, B. Savoldo, and C.M. Rooney Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease Acta Haematol 110 2003 139 148
97. D.J. Emanuel, K.G. Lucas, and G.B. Mallory Jr Treatment of posttransplant lymphoproliferative disease in the central nervous system of a lung transplant recipient using allogeneic leukocytes Transplantation 63 1997 1691 1694
98. M.A. Nalesnik, A.S. Rao, and A. Zeevi Autologous lymphokine-activated killer cell therapy of lymphoproliferative disorders arising in organ transplant recipients Transplant Proc 29 1997 1905 1906
99. T. Haque, P.L. Amlot, and N. Helling Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients J Immunol 160 1998 6204 6209
100. R. Khanna, S. Bell, and M. Sherritt Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease Proc Natl Acad Sci USA 96 1999 10391 10396
101. B. Savoldo, J. Goss, and Z. Liu Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients Transplantation 72 2001 1078 1086
102. P. Comoli, M. Labirio, and S. Basso Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication Blood 99 2002 2592 2598
103. T. Haque, G.M. Wilkie, and C. Taylor Treatment of Epstein-Barr-virus- positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells Lancet 360 2002 436 442
104. G. Frizzera, D.W. Hanto, and K.J. Gajl-Peczalska Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients Cancer Res 41 11 Pt 1 1981 4262 4279
105. D.M. Knowles, E. Cesarman, and A. Chadburn Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders Blood 85 1995 552 565